Solriamfetol (obstructive sleep apnoea) - Addendum to Commission A21-129

Report documents

1. Addendum

   Solriamfetol (obstructive sleep apnoea) - Addendum to Commission A21-129

   published on

   18.03.2022

   Document type

   PDF-Dokument, 334 kB, DE, PDF

   Download file : Addendum (PDF-Dokument, 334 kB, DE, PDF)

Additional information

Project details

Project no.

G22-06

Commission

Commission awarded on 09.03.2022 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Health Economics

Topic

Head and nerves

Note

If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.

Connected Projects

1. Dossier assessment

   Solriamfetol (obstructive sleep apnoea) - Benefit assessment according to §35a Social Code Book V

   Project no.

   A21-129

   Last updated

   18.03.2022

   Status: Commission completed